| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pathway | REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL | 7.38e-05 | 7 | 27 | 2 | MM15187 | |
| Pathway | REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL | 9.82e-05 | 8 | 27 | 2 | M27444 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 16314571 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 16118227 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 19141475 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.28e-05 | 1294 | 40 | 9 | 30804502 | |
| Pubmed | 7.05e-05 | 11 | 40 | 2 | 31045206 | ||
| Pubmed | 1.30e-04 | 85 | 40 | 3 | 23648065 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.45e-04 | 440 | 40 | 5 | 34244565 | |
| Pubmed | 1.80e-04 | 245 | 40 | 4 | 35652658 | ||
| Pubmed | An integrated genetic map of the pearl locus of mouse chromosome 13. | 2.18e-04 | 19 | 40 | 2 | 8828042 | |
| Pubmed | 2.18e-04 | 19 | 40 | 2 | 28369476 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 3.12e-04 | 1155 | 40 | 7 | 20360068 | |
| Pubmed | Tissue-Specific Gain of RTK Signalling Uncovers Selective Cell Vulnerability during Embryogenesis. | 3.80e-04 | 25 | 40 | 2 | 26393505 | |
| Pubmed | ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. | 4.12e-04 | 26 | 40 | 2 | 34162889 | |
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 4.78e-04 | 28 | 40 | 2 | 24462114 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 7.26e-04 | 954 | 40 | 6 | 36373674 | |
| Pubmed | 8.64e-04 | 162 | 40 | 3 | 23012479 | ||
| Pubmed | 8.79e-04 | 163 | 40 | 3 | 24316575 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 8.79e-04 | 163 | 40 | 3 | 22113938 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 1.12e-03 | 1038 | 40 | 6 | 26673895 | |
| Cytoband | 5q13 | 1.69e-04 | 22 | 40 | 2 | 5q13 | |
| Cytoband | 17q25.3 | 3.54e-03 | 101 | 40 | 2 | 17q25.3 | |
| Cytoband | 9q34.3 | 3.89e-03 | 106 | 40 | 2 | 9q34.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 5.02e-03 | 797 | 40 | 4 | chr19p13 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 184 | 40 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 171 | 40 | 4 | d9ad6a3bce3556abd24af1630bf4a99594437c3a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-05 | 183 | 40 | 4 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 2.21e-05 | 184 | 40 | 4 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 2.35e-05 | 187 | 40 | 4 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.40e-05 | 188 | 40 | 4 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 189 | 40 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.55e-05 | 191 | 40 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.55e-05 | 191 | 40 | 4 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.60e-05 | 192 | 40 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.60e-05 | 192 | 40 | 4 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.66e-05 | 193 | 40 | 4 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.71e-05 | 194 | 40 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.77e-05 | 195 | 40 | 4 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.77e-05 | 195 | 40 | 4 | bfaceb0601cf3855f38d6e1f482f01ad03ef11fe | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.82e-05 | 196 | 40 | 4 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-05 | 197 | 40 | 4 | 954d4deaeba50c5b3faf52105c4cde961a682be1 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.05e-05 | 200 | 40 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Disease | migraine disorder, endometriosis | 1.25e-04 | 73 | 39 | 3 | EFO_0001065, MONDO_0005277 | |
| Disease | differentiated thyroid carcinoma | 9.85e-04 | 35 | 39 | 2 | EFO_1002017 | |
| Disease | Facial wrinkling | 1.10e-03 | 37 | 39 | 2 | HP_0009762 | |
| Disease | obsolete_red blood cell distribution width | 1.73e-03 | 1347 | 39 | 7 | EFO_0005192 | |
| Disease | mean platelet volume | 2.07e-03 | 1020 | 39 | 6 | EFO_0004584 | |
| Disease | breast size | 3.78e-03 | 69 | 39 | 2 | EFO_0004884 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CRVVFDDTYDRSMLR | 66 | P07451 | |
| ERMEDRCRGEYERSF | 271 | Q9UJX6 | |
| RSVDRSLMYSEANRR | 276 | Q9NR09 | |
| SRQRLETEMQSYRCR | 1031 | Q8N2N9 | |
| RRMSRTFSECSYPET | 226 | P78524 | |
| SRRCVLMRLLDFSYE | 81 | Q969V3 | |
| CKLYSLRMFERRSFE | 516 | Q9Y561 | |
| VYSCRDAEMRRTFRR | 291 | Q9HBW0 | |
| RMRDRYDAFCFTSAL | 231 | Q9GZV7 | |
| SSLEYSECIRMARRD | 186 | P78333 | |
| AARRLYSRMEASCLE | 16 | Q86YR5 | |
| FRYRCRDAMRSVTKQ | 426 | Q9NY93 | |
| MYDVEKLVRTRSCRR | 171 | Q9C098 | |
| DTERYLYCRAMDRTS | 111 | Q08499 | |
| RCSMESYRENLERVF | 151 | Q9H1Q7 | |
| MEEFRRSYSRLCRES | 1 | Q96CN5 | |
| DDRYCESIMRRRGLT | 46 | P03950 | |
| EYSGTLRRNSMRECR | 671 | Q02413 | |
| RAFFRSCLDMREIER | 181 | O95672 | |
| FSRYESTRSGRRMEL | 76 | P04062 | |
| FNRENCDSRYDTMRR | 131 | Q6P988 | |
| CDSRYDTMRRLMSSR | 136 | Q6P988 | |
| RTLSRSVEYCAMRDE | 891 | Q6ZP82 | |
| MDKRDSFRRTRFSDR | 1001 | Q8NF50 | |
| SRSRDRMYSRDYRRD | 46 | Q9NYF8 | |
| RRDFDTLRCMLGRVY | 66 | Q9BQD1 | |
| DRKDRRRSMCYSDGR | 826 | Q69YH5 | |
| DMDDAYDRLTRHRCR | 521 | P07686 | |
| RSTRTRKCISYRFDE | 1011 | Q96T23 | |
| YRSADGRRFRQACDM | 256 | Q6NT55 | |
| RDYFSLMDCNRSFRV | 71 | Q8IWL3 | |
| MSRRTRCEDLDELHY | 1 | P10244 | |
| EALRRASYEFMRRSL | 101 | Q9NW61 | |
| SRRFRDYCSQMLSKE | 626 | Q96T21 | |
| EDYERRRSECVSEML | 51 | Q9HCU9 | |
| SSRVLEAMRRGYSRE | 406 | Q96SZ6 | |
| RASDRMRSRSEKDYR | 21 | Q9P2F5 | |
| RSTLCSRRMAEEFRL | 1046 | P24928 | |
| MSEEQLSRYEVCRRS | 101 | A6NLC8 | |
| DTRYVSSRCRSERER | 386 | Q9BYW2 | |
| YTKRRMCELSEDTRR | 221 | Q9NWH7 | |
| CFRKMEESSLETRRY | 241 | Q5H9K5 | |
| RYDFCARDMRELSLL | 796 | Q9UKW4 |